Athebio enables its partners to develop next-generation therapeutics based on leading-edge designed ankyrin repeat proteins (DARPins) - the Athebody® DARPins.
Products, services, technology
Athebody® DARPins offer game-changing advantages for generating targeted therapeutics, including high stability, small size, reliable folding, excellent target affinity & specificity, species cross-reactivity, ease of generating multi-specificity, superb developability, and good FTO prospects.
We strive to enable our partners with repeat protein technology in the best possible way. This can range from giving access to our know-how & proprietary Athebody® DARPin technology, to selecting custom Athebody® DARPins or setting up an inhouse Athebody® DARPin selection machinery for our partners.